Changzhou Qianhong Biopharma Hits Day High with 5.13% Surge

Changzhou Qianhong Biopharma Co., Ltd. has experienced a notable increase of 5.13% on March 24, 2026, reaching an intraday high of CNY 7.18. This performance stands out against the backdrop of the China Shanghai Composite, which rose by 1.78% on the same day. Despite a challenging week with a decline of 4.78% and a monthly drop of 8.08%, the company has shown resilience over the past year, boasting a 26.01% increase compared to the index's 15.17%. Year-to-date, however, Changzhou Qianhong has faced a decrease of 8.78%, while the broader market has declined by 2.21%. Financially, the company has reported positive results for the last three consecutive quarters, with a net profit of CNY 380.07 million and a return on capital employed (ROCE) of 16.45%. The firm has a price-to-earnings (P/E) ratio of 29.00 and a price-to-book value of 4.38, indicating an attractive valuation. Additionally, the company maintains a high dividend yield of 2.14%, reflecting its commitment to returning value to shareholders.